Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?-Reference-Cited by-同舟云学术

Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?

Published:2018-10 Issue:1 Volume:151 Page:24-31
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Tseng Jill H.,Cowan Renee A.,Zhou Qin,Iasonos Alexia,Byrne Maureen,Polcino Tracy,Polen-De Clarissa,Gardner Ginger J.,Sonoda Yukio,Zivanovic Oliver,Abu-Rustum Nadeem R.,Long Roche Kara,Chi Dennis S.

Funder

National Institutes of Health/National Cancer Institute

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference32 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

2. SEER Cancer Statistics Review, 1975–2015,2018

3. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma;Griffiths;Natl. Cancer Inst. Monogr.,1975

4. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study;Eisenkop;Gynecol. Oncol.,1998

5. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer;Zivanovic;Gynecol. Oncol.,2008

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Cytoreductive Surgery Versus Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: the Primary Cytoreductive Surgery is Better Than Neoadjuvant Chemotherapy in Platinum-resistant Patients;2024-07-23

2. ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer;International Journal of Gynecologic Cancer;2024-03-21

3. Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer;The Obstetrician & Gynaecologist;2024-03-15

4. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease;npj Genomic Medicine;2024-03-05

5. Extra-abdominal cytoreductive techniques in ovarian cancer: how far can (should) we go?;International Journal of Gynecologic Cancer;2024-03